Immunization, Hib3 in Arab World
Arab World: Immunization, Hib3 was 77.1% in 2024. ◆ Volatile
Immunization, Hib3 in Arab World, 1990–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
Arab World recorded 77.1% for immunization, hib3 in 2024.
That represents a change of down 2.3% on the previous year and down 9.7% over ten years.
Over the whole period, immunization, hib3 in Arab World peaked at 86.0% in 2017 and was at its lowest, 0.0%, in 1990.
Arab World ranks 27th of 43 groups on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, Hib3 in Arab World, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1990 | 0.0% | — |
| 1991 | 0.0% | — |
| 1992 | 0.0% | — |
| 1993 | 0.0% | — |
| 1994 | 0.0% | — |
| 1995 | 0.0% | — |
| 1996 | 0.0% | — |
| 1997 | 0.1% | — |
| 1998 | 0.7% | +490.2% |
| 1999 | 1.4% | +106.7% |
| 2000 | 1.4% | -0.5% |
| 2001 | 7.9% | +448.1% |
| 2002 | 14.2% | +80.0% |
| 2003 | 16.9% | +19.1% |
| 2004 | 16.8% | -0.6% |
| 2005 | 20.3% | +21.1% |
| 2006 | 21.7% | +6.9% |
| 2007 | 31.0% | +42.6% |
| 2008 | 50.0% | +61.5% |
| 2009 | 50.3% | +0.7% |
| 2010 | 50.9% | +1.1% |
| 2011 | 53.0% | +4.1% |
| 2012 | 56.5% | +6.7% |
| 2013 | 62.1% | +9.8% |
| 2014 | 85.3% | +37.4% |
| 2015 | 84.3% | -1.2% |
| 2016 | 84.9% | +0.8% |
| 2017 | 86.0% | +1.2% |
| 2018 | 85.4% | -0.6% |
| 2019 | 85.7% | +0.3% |
| 2020 | 82.0% | -4.3% |
| 2021 | 82.0% | +0.0% |
| 2022 | 84.3% | +2.8% |
| 2023 | 78.8% | -6.5% |
| 2024 | 77.1% | -2.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 0.2% | 0.0% | 1.4% | 10 |
| 2000s | 23.0% | 1.4% | 50.3% | 10 |
| 2010s | 73.4% | 50.9% | 86.0% | 10 |
| 2020s | 80.9% | 77.1% | 84.3% | 5 |
Countries ranked near Arab World
- 29 Albania 97.0% compare
- 29 Bangladesh 97.0% compare
- 29 Belgium 97.0% compare
- 29 Egypt 97.0% compare
- 29 Korea 97.0% compare
- 29 Latvia 97.0% compare
- 29 Malta 97.0% compare
- 29 Naoero 97.0% compare
- 29 Nepal 97.0% compare
- 29 Norway 97.0% compare
- 29 Saudi Arabia 97.0% compare
- 29 Singapore 97.0% compare
- 29 Sri Lanka 97.0% compare
- 29 Saint Kitts and Nevis 97.0% compare
- 29 Tajikistan 97.0% compare
- 29 Tunisia 97.0% compare
- 29 Viet Nam 97.0% compare
More health data for Arab World
- Population ages 45-49, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 50-54, male, annual growth rate 3.14 % change on previous year (2025)
- Population ages 50-54, female, per capita 0.0206 units per person (2025)
- Population ages 50-54, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0472 units per person (2025)
- Population ages 50-54, female, annual growth rate 3.04 % change on previous year (2025)
- Population ages 45-49, male, per capita 0.0278 units per person (2025)
- Population ages 45-49, female, annual growth rate 3.67 % change on previous year (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hib3 in Arab World?
- Immunization, hib3 in Arab World was 77.1% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Arab World?
- The highest recorded value was 86.0% in 2017.
- What is the lowest immunization, hib3 recorded in Arab World?
- The lowest recorded value was 0.0% in 1990.
- How does Arab World rank for immunization, hib3?
- Arab World ranks 27th out of 43 groups with data for 2024.
- Is immunization, hib3 rising or falling in Arab World?
- Over the last ten years it is down 9.7%. The long-run trend across the full record is volatile.
- Where does this Arab World data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.